GF SECURITIES
Search documents
银行资负跟踪:票据利率明显下行
GF SECURITIES· 2024-08-27 07:44
[Table_Page] 跟踪分析|银行 证券研究报告 [Table_Title] 银行资负跟踪 20240825 票据利率明显下行 [Table_Summary] 核心观点: ⚫ 本期:2024/8/19~8/25,上期:2024/8/12~8/18,下期:2024/8/26~9/1。 ⚫ 央行动态:据 Wind 数据(下同),本期央行公开市场共开展 11,978 亿 元 7 天逆回购操作,利率 1.70%,逆回购到期 15,449 亿元,整体实现 净回笼 3,471 亿元。下期央行公开市场将有 11,978 亿元逆回购到期。本 期央行逆回购余额有所回落,但依旧明显高于季节性,周五逆回购余额 再次扩张,市场或已开始储备跨月流动性备付,银行间流动性中性偏紧。 下期政府债缴款压力不大,但跨月资金面扰动下预计逆回购余额维持高 位,同时关注下期 MLF 续作量价。 ⚫ 政府债融资:本期政府债净缴款 763 亿元,预计下期政府债净缴款约 559 亿元,较本期有所回落。8 月下旬政府债净融资有所放缓,全月累计规 模超季节性,关注后续节奏上的持续性。 ⚫ 资金利率:本期资金利率震荡回升,下期跨月,预计资金利率继续回升, ...
澳华内镜:公司业绩符合预期,加速海外市场产品准入
GF SECURITIES· 2024-08-27 04:00
[Table_Page] 中报点评|医疗器械 证券研究报告 [Table_Title] 澳华内镜(688212.SH) 公司业绩符合预期,加速海外市场产品准入 [Table_Summary] 核心观点: 公司业绩符合预期。根据公司 24 年半年报,24 年上半年,公司营收 3.54 亿元(YOY+22.29%);归母净利润 0.06 亿元(YOY-85.13%), 系公司的限制性股票激励计划和人力的持续投入增加;毛利率 71.46% (YOY-4.82pp),主要系公司成本随营收增加而增加。根据 wind,公 司 24 年 2 季度实现收入 1.84 亿元(YOY+12.61%);归母净利润 0.03 亿元,环比增速 5.17%。 公司费率整体略增。根据 wind,公司 24 年上半年,销售费用率 34.69% (YOY+0.52pp),主要系职工薪酬及差旅费等费用增长;管理费用率 16.6%(YOY+2.69pp),主要系股份支付差旅费等费用增加;研发费用 率 24.7%(YOY+0.62pp),主要系职工薪酬及差旅费等费用增长。 公司新产品陆续迭代,加速海外市场产品准入。根据公司 24 年半年 报,24 ...
亿纬锂能:储能电池出货增速陡峭,消费板块稼动率企稳回升
GF SECURITIES· 2024-08-27 03:59
Investment Rating - The report assigns a "Buy" rating to the company, with a current price of 33.18 CNY and a reasonable value of 43.34 CNY per share [2]. Core Insights - The company's performance in the first half of 2024 met expectations despite impairment losses, with revenue of 21.659 billion CNY, down 5.73% year-on-year, and a net profit of 2.137 billion CNY, down 0.64% year-on-year. The non-recurring net profit increased by 19.32% year-on-year to 1.499 billion CNY [2][3]. - The steep growth in energy storage battery shipments and the stabilization of the consumer battery segment's operating rate are notable. The energy storage business revenue rose by 9.93% year-on-year to 7.774 billion CNY, with a shipment volume of 20.95 GWh, up 133.18% year-on-year [3]. - The company is expected to benefit from stable pricing in the battery market, particularly in commercial vehicle batteries, and has a strong order backlog for energy storage batteries, which will support overseas market expansion [3]. Financial Summary - For the first half of 2024, the company reported a revenue of 21.659 billion CNY, with a year-on-year decline of 5.73%. The net profit attributable to shareholders was 2.137 billion CNY, down 0.64% year-on-year, while the non-recurring net profit increased by 19.32% to 1.499 billion CNY [2][3]. - The second quarter of 2024 saw revenue of 12.342 billion CNY, a year-on-year increase of 4.68%, and a net profit of 1.072 billion CNY, up 5.97% year-on-year [2][3]. - The company forecasts EPS of 2.17 CNY, 2.78 CNY, and 3.39 CNY for 2024, 2025, and 2026 respectively, with a target PE of 20 times for a reasonable value of 43.34 CNY per share [3].
阳光电源:业绩超预期,全球储能影响力持续提升
GF SECURITIES· 2024-08-27 03:59
[Table_Title] 阳光电源(300274.SZ) 业绩超预期,全球储能影响力持续提升 [Table_Summary] 核心观点: 公司发布 2024 年半年报,业绩超预期。24 年上半年公司实现营收 310.20 亿元,同比+8.38%;毛利率 32.42%,同比+3.0pct,主要系公 司品牌溢价、产品创新及项目管理能力的提高;归母净利润 49.59 亿 元,同比+13.89%;财务费用 1.88 亿元,同比增长 4.97 亿元,主要系 汇兑损失金额大幅增加。24Q2 实现营收 184.06 亿元,同比+14.74%, 环比+45.92%;归母净利润 28.63 亿元,同比+0.57%,环比+36.56%。 逆变器业务经营稳健,微逆新品开拓欧洲户用市场。根据公司中报, 24 年上半年光伏逆变器业务出货 65GW,实现营收 130.93 亿元,同 比+12.63%,占总营收 42.21%,毛利率稳定在 38%左右。公司大力推 进全球化品牌战略,加码布局欧洲、美洲、澳洲、中国渠道市场,全球 服务网点增长至 490+。公司重磅发布微逆系列及家庭智慧能源管理器 iHomeManager,方便适应欧洲及全球 ...
老板电器:Q2业绩受地产拖累,中期分红回报股东
GF SECURITIES· 2024-08-27 03:58
[Table_Page] 中报点评|家用电器 证券研究报告 [Table_Title] 老板电器(002508.SZ) Q2 业绩受地产拖累,中期分红回报股东 [Table_Summary] 核心观点: ⚫ 老板电器发布 2024 年中报。24H1 营业收入 47.3 亿元(YoY-4.2%); 归母净利润 7.6 亿元(YoY-8.5%)。毛利率 48.9%(YoY-3.1pct),归 母净利率 16.1%(YoY-0.8pct)。24Q2 单季收入 24.9 亿元(YoY-9.6%); 归母净利润 3.6 亿元(YoY-18.2%)。 ⚫ 24H1 厨电行业受地产拖累整体承压,老板电器龙头地位稳固。行业 方面,根据公司中报引用的奥维数据,24H1 住宅竣工面积 19259 万 平方米,同比下降 21.7%,导致厨电行业新增需求明显下滑。虽然行 业总体承压,但老板电器市场份额依然稳固。根据奥维线下报告显示, 老板品牌吸油烟机零售额、零售量市场占有率为 31.9%、26.1%;根 据奥维线上报告显示,老板品牌厨电套餐零售额、零售量市场占有率 为 27.0%、20.9%;均位于行业第一。 ⚫ 盈利能力整体承压, ...
机械设备行业周报:美联储发出降息信号,外需有望迎来改善
GF SECURITIES· 2024-08-27 03:55
[Table_Page] 投资策略周报|机械设备 [Table_Title] 机械设备行业周报 美联储发出降息信号,外需有望迎来改善 [Table_Summary] 核心观点: 证券研究报告 [Table_Grade] 行业评级 买入 前次评级 买入 报告日期 2024-08-25 ⚫ 鲍威尔表示美联储降息时机已到。根据中新社,美国联邦储备委员会 主席鲍威尔 23 日在怀俄明州举行的杰克逊霍尔全球央行年度经济政 策研讨会上表示,美联储降息时机已到。鲍威尔在讲话中称,高通胀是 一个全球现象,反映了人们的共同经历。美联储毫不畏惧地履行职责, 其行动表明了恢复价格稳定的决心。自 2023 年 7 月以来,美联储一直 将联邦基金利率维持在限制水平。目前,通胀的上行风险已经减弱。鲍 威尔说,政策调整的时机已经到来,政策方向已经明确。降息的时间和 节奏将取决于即将发布的数据、不断变化的前景和风险平衡情况。 ⚫ 市场表现分析:本周(8 月 19 日-8 月 23 日)机械行业指数(中信) 下跌 2.70%,沪深 300 指数下跌 0.55%,创业板指下跌 2.80%。 ⚫ 机械动态变化:广义货币增长 6.3%,前七个月人民 ...
房地产及物管行业24年第34周周报:住建工作聚焦新模式&保交房,二手网签成交止跌
GF SECURITIES· 2024-08-26 13:38
Xml [Table_Page] 跟踪分析|房地产 证券研究报告 [Table_Title] 房地产及物管行业 24 年第 34 周周报 住建工作聚焦新模式&保交房,二手网签成交止跌 [Table_Summary] 核心观点: ⚫ 本周政策情况:多维度推进发展新模式,融资协调机制助力保交房。 中央政策方面,本周国新办"推动高质量发展"系列新闻发布会陆续 召开,8 月 21 日金融监管总局强调完善融资协调机制以更好支持保交 房工作,8 月 23 日住建部主要围绕新模式以及保交房展开。地方政策 方面,本周厦门出台购房落户政策,长沙将住房认定标准缩小为所在 区,长沙、兰州等地积极推动收储,上海拟出台房屋体检、保险、养 老金三项制度,金山区发放首张房票。 ⚫ 本周基本面情况:推盘中枢下行,二手房网签成交止跌。据 Wind 及 克尔瑞,本周 51 城新房成交面积 374.4 万方,环比上升 6.3%,同比 下降 13.2%,新房成交热度略低于去年同期,当前新房成交热度低位 维稳。二手房方面,本周 13 城网签口径成交 149.7 万方,环比下降 0.4%,同比上升 14.2%,74 城认购口径日均成交 1785 套,环 ...
固废行业巡礼(一):特许经营权到期、国补退坡问题解答
GF SECURITIES· 2024-08-26 13:38
[Table_Page] 深度分析|环保 证券研究报告 [Table_Title] 固废行业巡礼(一) 特许经营权到期、国补退坡问题解答 [Table_Summary] 核心观点: ⚫ 引言:2024 年以来固废公司因其民生属性、盈利稳健、自由现金流大 幅改善等特点而备受市场关注,光大环境、瀚蓝环境、三峰环境等 2024 年至今涨幅分别为 48%、26%、21%,显著跑赢沪深 300、上证等行 业指数。我们推出"固废行业巡礼"系列报告,旨在对市场关心的重点 问题做出研究及解答,本篇"系列一"主要聚焦"特许经营权到期"及 "国补退坡"两个问题。 ⚫ 特许经营权到期问题:早期项目仅占比 5%以内,政策&实践案例均提 供了延期至 40 年的可能。固废项目大多采用特许经营权模式,项目期 限大多为 25~30 年,市场普遍担心到期后项目会移交给政府因而影响 上市公司的资产规模、利润体量。我们梳理了固废上市公司在运产能情 况,2010 年及以前投运的项目占公司总在运产能的比重约为 5%(千 吨左右),假设 25 年的经营期限,即 2035 年前项目到期的影响有限。 从政策指引来看,2024 年特许经营权新规发布,政策指引 ...
兴业银行:规模稳健扩张,利润增速转正
GF SECURITIES· 2024-08-23 10:40
Investment Rating - The report maintains a "Buy" rating for the company [4]. Core Views - The company reported a positive growth in revenue, PPOP, and net profit attributable to shareholders for the first half of 2024, with year-on-year increases of 1.8%, 3.7%, and 0.9% respectively. Although there was a slight decline in growth rates compared to the first quarter of 2024, the overall performance remains stable [2][3]. - Key highlights include a significant improvement in deposit costs, with a net interest margin of 1.86% and a reduction in deposit cost rate by 18 basis points compared to the full year of 2023. The company also experienced steady asset growth, with total assets increasing by 4.6% year-on-year [2][3]. - The report indicates that the company's internal capital growth rate exceeds the growth rate of risk-weighted assets, suggesting sustainability in dividend payouts and high dividend value [2][3]. Summary by Relevant Sections Financial Performance - For the first half of 2024, the company achieved a revenue growth of 1.8%, PPOP growth of 3.7%, and a net profit growth of 0.9% compared to the previous year. The growth rates for revenue and PPOP showed a decline of 2.4 percentage points and 3.5 percentage points respectively from the first quarter of 2024, while net profit growth turned positive with an increase of 4.0 percentage points [2][3][11]. - The net interest margin for the first half of 2024 was reported at 1.86%, with a marginal decline of only 1 basis point from the previous quarter, indicating stabilization [2][3][11]. Asset Quality - The non-performing loan ratio at the end of the first half of 2024 was 1.08%, showing a slight increase of 1 basis point from the end of the first quarter. The company also reported a rise in the restructured loan ratio and a decrease in the provision coverage ratio [3][11][19]. Growth and Expansion - The company’s total assets grew by 4.6% year-on-year, with risk-weighted assets increasing by 5.5%. The internal capital growth rate was reported at 7.7%, which is higher than the growth rate of risk-weighted assets, indicating a robust capital position [2][3][11]. Profitability Forecast - The report forecasts a net profit growth of 3.87% and 3.86% for the years 2024 and 2025 respectively, with expected earnings per share of 3.65 and 3.80 yuan per share. The current stock price corresponds to a price-to-earnings ratio of 4.60X and 4.42X for 2024 and 2025 respectively [2][3][11].
南微医学:公司24年中期业绩符合预期,海外建设/降本增效两手抓
GF SECURITIES· 2024-08-23 10:40
Investment Rating - The report maintains a "Buy" rating for the company with a target price of 74.90 CNY per share, corresponding to a 24-year PE of 25X [1][2] Core Views - The company's performance met expectations, with both domestic and international markets contributing to growth [1] - Revenue for the first half of 2024 reached 1.334 billion CNY, a YoY increase of 16.28%, driven by increased product sales in overseas markets [1] - Domestic market revenue was approximately 706 million CNY (YoY +1.73%), while international market revenue reached 624 million CNY (YoY +39.72%) [1] - Net profit attributable to the parent company was 310 million CNY, a YoY increase of 17.47%, with a gross margin of 67.94% (YoY +4.2pp) [1] - The company's overall expense ratio has been optimized, with sales expenses at 22.73% (YoY +0.68pp), management expenses at 12.43% (YoY -0.85pp), and R&D expenses at 5.22% (YoY -0.77pp) [1] Overseas Expansion and Cost Efficiency - The company has made significant progress in overseas construction, including the establishment of a European regional headquarters and the acquisition of channel companies in Portugal and Switzerland [1] - The US subsidiary has strengthened its local sales team, leading to a significant improvement in profits [1] - The company has set up an Australian office and is progressing with the construction of a production base in Thailand, expected to be operational by 2026 [1] - Operational improvements focus on "lean management efficiency, resource integration optimization, and process innovation cost reduction" to achieve sustainable profit growth [1] Financial Projections - EPS for 2024-2026 is projected to be 3.04 CNY/share, 3.83 CNY/share, and 4.89 CNY/share, respectively [1] - Revenue growth is expected to be 19.2% in 2024, 22.9% in 2025, and 23.7% in 2026 [3] - Net profit attributable to the parent company is forecasted to grow by 17.6% in 2024, 25.8% in 2025, and 27.7% in 2026 [3] Industry and Market Position - The company is a leader in the digestive endoscopy consumables sector, with a solid foundation in existing products and significant potential in the development of visualization products [1] - The recent easing of medical device centralized procurement policies has alleviated previous valuation pressures [1]